ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 681,500 | $2,481,000 | 1.19% |
DAFNA Capital Management LLC | 26,000 | $95,000 | 0.04% |
Rossmore Private Capital | 15,061 | $55,000 | 0.02% |
Sterling Investment Advisors, Ltd. | 3,150 | $11,000 | 0.01% |
Close Asset Management Ltd | 7,500 | $27,000 | 0.00% |
SeaCrest Wealth Management, LLC | 1,500 | $5,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,506 | $5,000 | 0.00% |
MORGAN STANLEY | 26,701 | $97,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 1,600 | $6,000 | 0.00% |